Skip to main content
Signal8

SAPIRSTEIN JAMES

SEC insider (Form 3/4/5 filer). CIK 0001559509. Director at Inmune Bio, Inc. (INMB) and 3 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in BOCA RATON, FL.

Companies SAPIRSTEIN JAMES has filed insider reports for

  • Inmune Bio, Inc. (INMB): Director
  • Cocrystal Pharma, Inc. (COCP): Officer, Chief Executive Officer
  • ZyVersa Therapeutics, Inc. (ZVSA): Director
  • Onconetix, Inc. (ONCO): Director
SAPIRSTEIN JAMES profile photo

SAPIRSTEIN JAMES

CIK: 0001559509

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Inmune Bio, Inc. logo
INMB

Inmune Bio, Inc.

Director
Cocrystal Pharma, Inc. logo
COCP

Cocrystal Pharma, Inc.

Officer
ZyVersa Therapeutics, Inc. logo
ZVSA

ZyVersa Therapeutics, Inc.

Director
Onconetix, Inc. logo
ONCO

Onconetix, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Inmune Bio, Inc. logo
    INMB

    Inmune Bio, Inc.

    Sep 15, 2026
    Award

    Stock Options

    Direct
    100K shares-
  • Cocrystal Pharma, Inc. logo
    COCP

    Cocrystal Pharma, Inc.

    Jun 3, 2026
    Award

    Stock Options (Right to Buy)

    Direct
    235K shares-
  • ZyVersa Therapeutics, Inc. logo
    ZVSA

    ZyVersa Therapeutics, Inc.

    Jul 11, 2025
    Award

    Stock Options

    Direct
    11.1K shares-
  • Onconetix, Inc. logo
    ONCO

    Onconetix, Inc.

    Sep 26, 2024
    Award
    Direct
    3.3K shares-

1-4 of 4